Avenzo Therapeutics Announces $60 Million Series B Financing
Financing led by OrbiMed and SR One, with participation from all existing investors and new institutional investor Longwood Fund Proceeds to advance Avenzo’s portfolio of potential best-in-class oncology drug candidates SAN DIEGO–(BUSINESS WIRE)–Avenzo Therapeutics, Inc. (“Avenzo”),…